Aldehyde dehydrogenase activity as a functional marker for lung cancer. - Wikidata - wikimedia - TriplyDB

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

http://www.wikidata.org/entity/Q39925109

about

Identification of CBX3 and ABCA5 as putative biomarkers for tumor stem cells in osteosarcoma Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties Molecular biology of lung cancer: clinical implications Cancer stem cells: a metastasizing menace!Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition CD24+/CD38- as new prognostic marker for non-small cell lung cancer.The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer Breast cancer stem cells: tools and models to rely on.Isolation of cancer progenitor cells from cancer stem cells in gastric cancer Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells Aldehyde dehydrogenase 3B1 (ALDH3B1): immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition.Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics Essential role of the cancer stem/progenitor cell marker nucleostemin for indole-3-carbinol anti-proliferative responsiveness in human breast cancer cells.Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer.Immunohistochemical analysis of aldehyde dehydrogenase isoforms and their association with estrogen-receptor status and disease progression in breast cancer Seeing is believing: are cancer stem cells the Loch Ness monster of tumor biology?Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.IL-8 confers resistance to EGFR inhibitors by inducing stem cell properties in lung cancer.ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets.Engineering cancer stem-like cells from normal human lung epithelial cells.ALDH/CD44 identifies uniquely tumorigenic cancer stem cells in salivary gland mucoepidermoid carcinomas.Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells.Downregulation of ALDH1A1 expression in non-small cell lung carcinomas--its clinicopathologic and biological significance Mucin 1-mediated chemo-resistance in lung cancer cells.Detection of ALDH1 activity in rabbit hepatic VX2 tumors and isolation of ALDH1 positive cancer stem cells Mechanisms of chemoresistance in cancer stem cells.Ocular aldehyde dehydrogenases: protection against ultraviolet damage and maintenance of transparency for vision.Multiple pluripotent stem cell markers in human anaplastic thyroid cancer: the putative upstream role of SOX2.A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin Cancer stem cells in lung cancer: Evidence and controversies.The role of human aldehyde dehydrogenase in normal and cancer stem cells.Cancer stem cell markers: what is their diagnostic value?Constitutive expression and activation of stress response genes in cancer stem-like cells/tumour initiating cells: potent targets for cancer stem cell therapy.Therapy-induced enrichment of putative lung cancer stem-like cells.Histone modifications: Targeting head and neck cancer stem cells.Cervical cancer stem cells: opportunities and challenges.

P2860

Q21560783-CF403AEF-023B-4399-AE0E-A629B8FCAE11 Q21562142-CC6FEC01-910C-4782-B872-8B1FD5C752DD Q24610335-7B648FFE-A40D-4021-ADCD-5DBE9CA1FDBC Q26771651-2AD67A66-B7B9-4235-AC8F-B133A9C21C48 Q28477031-67989B92-C0D0-44EE-8A6C-5324E5C7C4D1 Q30446381-2DB352D3-3049-43FD-A3C1-9C39858803D9 Q33470317-C9C7B3E2-7D32-4C32-9F74-2EF5A3371ADB Q33474554-78609854-FEDE-4B21-ADB2-2A597E1F80E0 Q33702282-EA08780D-E9AF-4AD2-8283-B6A45EAEB50F Q34026132-41368908-702C-4FF8-A162-BD39A0E31A0B Q34076679-A7A534C6-40F5-4351-8E33-DC7E3ECE206A Q34105402-4877BC93-9EE4-46D8-8530-31A834F19890 Q34267466-568D4A93-8384-4C0C-A417-AFBED667E9BE Q34270803-DA2FC784-D97E-4CAE-99EA-BFEE2A3E06A8 Q34420393-2A0FDA87-698F-4743-B7B9-16380478C253 Q34731134-E85A9C1E-60B6-49FF-A762-611A53AAFE17 Q34978487-91CC224F-4F38-4B75-919E-13620F0FE701 Q35038324-C760AD56-08AA-434C-8963-BA6DB4EA4FC9 Q35058948-75B992BB-992A-4ED3-9AE0-F74D3914BDD2 Q35130660-5D0450F5-F2E2-4168-BC85-EC3E825F03F3 Q35833023-E2992A09-A566-45DF-8996-0F7222764A63 Q36252693-4483C7B8-9405-4B6B-ABAC-DBEADB99DF24 Q36336130-A50D62D9-C700-4101-A19A-BFE3D3278D24 Q36413567-5DB17F10-B654-4859-865A-AD1CD90369B3 Q36429978-7A3C793A-A91C-4151-9EFC-31ED9B5C170E Q36449835-FF33932E-49A8-4BAB-82F6-B6F36B391F2C Q36507586-988D26C5-3C9D-4B5B-9B22-3982A73A98EC Q36577658-B6586C32-1ED6-4F8E-97DA-661A5FCFD3F5 Q36591484-16840692-C57D-407D-A05B-E1E3DAB66819 Q36604845-175354C7-F636-41C5-B114-8C842BD25017 Q36991654-861392E4-F3A0-4213-BB42-6FC9D87E59D7 Q37100176-8352D8F3-2A80-4277-AF7F-EFE76CDE733D Q37636636-CD6CA1B6-FC38-4DBD-8F34-7E35720F41B4 Q37709551-E12085B5-E56D-4946-BF95-7095FA71DA91 Q37811959-970E9961-1714-4B49-9ECC-9A7F1386E642 Q38089898-589C5DF9-AF55-45C7-BEE1-0CB3DDAFD988 Q38125515-9C32F581-95E1-4117-9927-882FE1FF71A6 Q38150766-10532671-D553-410E-9901-C9C0ADA5C558 Q38271597-E4F0E46D-0793-4E28-ACA0-8439AFE57508 Q38309029-1C3FFCBC-7AC2-4313-9492-2A3C850EC8FA

P2860

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

http://www.wikidata.org/entity/Q39925109

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

@en

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

@nl

type

label

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

@en

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

@nl

prefLabel

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

@en

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

@nl

P1433

Q39925109-048DABAE-DA1A-4B25-8823-8DAE0C92982F

P1476

Q39925109-9EA7DA66-E210-402D-9674-7790F1DF771E

P2093

Q39925109-190BAB53-D88B-4206-AAA1-93398F23F18D

Q39925109-1E532F35-3F98-4342-8425-386CBF5EABE4

Q39925109-3C9C8F0A-2DEA-4BE3-A8F3-CB17BC1A0B2F

Q39925109-4E6EF075-2223-4106-BA2F-277F85968BCB

Q39925109-7C9D08E0-9E75-4DCD-8E05-F5F5846AEEF5

Q39925109-C33FEECD-15FF-40FA-A6CA-58D57652B3E1

Q39925109-D2B3B369-8164-4245-8273-1BD3177B0D1E

P2860

Q39925109-11F8868E-202C-4981-9CCA-DC08352A9D76

Q39925109-1365D0E8-9DB7-404A-AA85-B52EF1585060

Q39925109-2635ED53-A770-47AD-A4EC-E6123C0411E8

Q39925109-2B395703-26DD-4575-9D66-5A6E4E0EA52E

Q39925109-2E268F8C-87D9-469A-9F2A-4A77C7177D64

Q39925109-3C37521A-3FF3-49D6-B0D1-49D4E584C073

Q39925109-51D60CBF-D515-4E43-82DB-FB1E83E96A0D

Q39925109-53565F80-3E4E-4775-8ABA-1C07CA270192

Q39925109-6B36412D-D79E-4265-8F98-E7F460C2E249

Q39925109-6E1C2737-C728-4622-8A8D-10CDBB4CE858

P304

Q39925109-A6A44EF5-9915-4919-857E-FD5065E8A80D

P31

Q39925109-988F4231-985A-4551-89A4-3CFAF61F507A

P356

Q39925109-A4AE2612-8FD3-4A50-BD8B-949908B13F09

P433

Q39925109-B1C81600-0713-4255-8527-9E5B015DE385

P478

Q39925109-B6B773C8-994A-4621-B3FA-12C1E711EF39

P50

Q39925109-8E945BE0-FEDE-436A-9672-50B78966C690

P577

Q39925109-D32B54AE-A9D6-4D9D-8C7F-6FC22A74556C

P5875

Q39925109-8EA57B55-E1F7-49CC-A8BA-9C6FEA20B6B4

P698

Q39925109-8A9D5888-7B58-4156-B877-CD3EBF770EBD

P932

Q39925109-21E0B600-AF16-4DC4-A816-4A67F55FF567

P356

J.CBI.2008.09.029

P1433

Chemico-biological Interactions

P1476

Aldehyde dehydrogenase activity as a functional marker for lung cancer.

@en

P2093

Blanca Ostmark

http://www.w3.org/2001/XMLSchema#string

Brian A Gray

http://www.w3.org/2001/XMLSchema#string

Deniz Ucar

http://www.w3.org/2001/XMLSchema#string

Edward W Scott

http://www.w3.org/2001/XMLSchema#string

James R Zucali

http://www.w3.org/2001/XMLSchema#string

Jan S Moreb

http://www.w3.org/2001/XMLSchema#string

Robert Zori

http://www.w3.org/2001/XMLSchema#string

P2860

Multiple and additive functions of ALDH3A1 and ALDH1A1: cataract phenotype and ocular oxidative damage in Aldh3a1(-/-)/Aldh1a1(-/-) knock-out mice

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

Embryonic retinoic acid synthesis is essential for early mouse post-implantation development

Pharmacological profiling of disulfiram using human tumor cell lines and human tumor cells from patients

A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment

A perivascular niche for brain tumor stem cells

SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells

Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines.

P304

48-55

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CBI.2008.09.029

http://www.w3.org/2001/XMLSchema#string

P433

1-3

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Christopher R. Cogle

P577

2008-10-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23415341

http://www.w3.org/2001/XMLSchema#string

P698

18952074

http://www.w3.org/2001/XMLSchema#string

P932

2976869

http://www.w3.org/2001/XMLSchema#string